NeuBase Therapeutics, Inc. Quarterly Depreciation in USD from Q4 2010 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
NeuBase Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from Q4 2010 to Q3 2023.
  • NeuBase Therapeutics, Inc. Depreciation for the quarter ending September 30, 2023 was $100K, a 50% decline year-over-year.
  • NeuBase Therapeutics, Inc. Depreciation for the twelve months ending September 30, 2023 was $700K, a 12.5% decline year-over-year.
  • NeuBase Therapeutics, Inc. annual Depreciation for 2021 was $400K, a 300% increase from 2020.
  • NeuBase Therapeutics, Inc. annual Depreciation for 2020 was $100K, a 400% increase from 2019.
  • NeuBase Therapeutics, Inc. annual Depreciation for 2019 was $20K, a 95.7% increase from 2018.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $700K $100K -$100K -50% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $800K $200K $0 0% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $800K $200K $0 0% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $800K $200K $0 0% Oct 1, 2022 Dec 31, 2022 10-QT 2023-06-05
Q3 2022 $800K $200K +$80K +66.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $720K $200K +$100K +100% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $620K $200K +$120K +150% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $500K $200K +$100K +100% Oct 1, 2021 Dec 31, 2021 10-QT 2023-06-05
Q3 2021 $400K $120K +$110K +1100% Jul 1, 2021 Sep 30, 2021 10-K 2021-12-23
Q2 2021 $290K $100K +$70K +233% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $220K $80K +$50K +167% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $170K $100K +$70K +233% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-11
Q3 2020 $100K $10K $0 0% Jul 1, 2020 Sep 30, 2020 10-K 2021-12-23
Q2 2020 $100K $30K +$20K +200% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 $80K $30K +$30K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 $50K $30K +$30K Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-11
Q3 2019 $20K $10K Jul 1, 2019 Sep 30, 2019 10-K 2020-12-23
Q2 2019 $10K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 $0 Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q4 2018 $0 -$2.87K -100% Oct 1, 2018 Dec 31, 2018 10-Q 2020-03-26
Q4 2017 $2.87K -$12.9K -81.8% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-14
Q4 2016 $15.7K +$694 +4.61% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-14
Q4 2015 $15K +$7.41K +97% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-14
Q4 2014 $7.64K +$4.72K +161% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-09
Q4 2013 $2.92K +$557 +23.6% Oct 1, 2013 Dec 31, 2013 10-Q/A 2015-02-10
Q4 2012 $2.36K $0 0% Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-14
Q4 2011 $2.36K +$1.11K +89.1% Oct 1, 2011 Dec 31, 2011 10-Q 2013-02-19
Q4 2010 $1.25K Oct 1, 2010 Dec 31, 2010 10-Q/A 2012-02-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.